Andy Willmer

Andy Willmer is an experienced professional in the pharmaceutical and healthcare communications industries, currently serving as the Pharmaceutical Client Strategy and Partnership lead at Sciterion since August 2024. Prior to this role, Andy held the position of Executive Vice President of Strategy and Innovation at Symbiotix, LLC from August 2018 to August 2024. Andy's extensive background includes leadership roles such as Managing Director at LightHouse Medical Communications, Executive Vice President and General Manager at Ogilvy CommonHealth Worldwide, and Senior Vice President at Health4Brands Catapult. Notable achievements also include serving as Client Service Director at Euro RSCG Life Catapult and working with major companies like Havas Life, Roche, Biovail, and Pfizer in various management and brand direction capacities. Andy holds a BSc (Hons) in Microbiology and Genetics from Cardiff University and completed earlier education at King James' College.